Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EAA-090

Known as: EAA 090, Perzinfotel 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To investigate the ability of perzinfotel (an N-methyl-d-aspartate receptor antagonist) and a proprietary phospholipase… Expand
Is this relevant?
2010
2010
The NMDA antagonist Perzinfotel was tested for anaesthetic sparing properties in telemetered dogs and cats when used in a pre… Expand
Is this relevant?
2009
2009
OBJECTIVE-To determine the effects of IV administration of perzinfotel and a perzinfotel-fentanyl combination on the minimum… Expand
  • table 1
  • table 2
Is this relevant?
2009
2009
Previous studies with perzinfotel (1), a potent, selective, competitive NMDA receptor antagonist, showed it to be efficacious in… Expand
  • figure 1
  • table 2
  • figure 2
  • table 3
  • figure 3
Is this relevant?
2007
2007
OBJECTIVE To determine the effect of IV administration of perzinfotel on the minimum alveolar concentration (MAC) of isoflurane… Expand
Is this relevant?
2005
2005
Perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] is a selective, competitive N… Expand
Is this relevant?
2005
2005
Perfusion of acute hippocampal slices with stimulatory buffers has long been known to induce rhythmic, large amplitude… Expand
Is this relevant?
2004
2004
Two novel N-methyl-d-aspartate (NMDA) antagonists with unique chemical structures, EAA-090 (2-[8,9-dioxo-2, 6-diazabicyclo[5.2.0… Expand
Is this relevant?
2002
2002
EAA-090 is a novel squaric acid amide derivative that has been identified as a potential treatment for the ischemic brain damage… Expand
Is this relevant?
1998
1998
The diazabicyclic amino acid phosphonate 15, [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid, was… Expand
Is this relevant?